Back

Biallelic variants in POPDC2 cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathy

Nicastro, M.; Vermeer, A. M. C.; Postema, P. G.; Tadros, R.; Bowling, F. Z.; Aegisdottir, H. M.; Tragante, V.; Mach, L.; Postma, A. V.; Lodder, E. M.; Duijvenboden, K. v.; Zwart, R.; Beekman, L.; Wu, L.; van der Zwaag, P. A.; Alders, M.; Allouba, M.; Aguib, Y.; Santomel, J. L.; Una, D. d.; Monserrat, L.; Miranda, A. M. A.; Kanemaru, K.; Cranley, J.; van Zeggeren, I. E.; Aronica, E. M. A.; Ripolone, M.; Zanotti, S.; Sveinbjornsson, G.; Ivarsdottir, E. V.; Holm, H.; Guobjartsson, D. F.; Skuladottir, A. T.; Stefansson, K.; Nadauld, L.; Knowlton, K. U.; Ostrowski, S. R.; Sorensen, E.; Pedersen, O.

2024-07-05 genetic and genomic medicine
10.1101/2024.07.04.24309755
Show abstract

POPDC2 encodes for the Popeye domain-containing protein 2 which has an important role in cardiac pacemaking and conduction, due in part to its cAMP-dependent binding and regulation of TREK-1 potassium channels. Loss of Popdc2 in mice results in sinus pauses and bradycardia and morpholino knockdown of popdc2 in zebrafish results in atrioventricular (AV) block. We identified bi-allelic variants in POPDC2 in 4 families that presented with a phenotypic spectrum consisting of sinus node dysfunction, AV conduction defects and hypertrophic cardiomyopathy. Using homology modelling we show that the identified POPDC2 variants are predicted to diminish the ability of POPDC2 to bind cAMP. In in vitro electrophysiological studies we demonstrated that, while co-expression of wild-type POPDC2 with TREK-1 increased TREK-1 current density, POPDC2 variants found in the patients failed to increase TREK-1 current density. While patient muscle biopsy did not show clear myopathic disease, it showed significant reduction of the expression of both POPDC1 and POPDC2, suggesting that stability and/or membrane trafficking of the POPDC1-POPDC2 complex is impaired by pathogenic variants in any of the two proteins. Single-cell RNA sequencing from human hearts demonstrated that co-expression of POPDC1 and 2 was most prevalent in AV node, AV node pacemaker and AV bundle cells. Sinoatrial node cells expressed POPDC2 abundantly, but expression of POPDC1 was sparse. Together, these results concur with predisposition to AV node disease in humans with loss-of-function variants in POPDC1 and POPDC2 and presence of sinus node disease in POPDC2, but not in POPDC1 related disease in human. Using population-level genetic data of more than 1 million individuals we showed that none of the familial variants were associated with clinical outcomes in heterozygous state, suggesting that heterozygous family members are unlikely to develop clinical manifestations and therefore might not necessitate clinical follow-up. Our findings provide evidence for POPDC2 as the cause of a novel Mendelian autosomal recessive cardiac syndrome, consistent with previous work showing that mice and zebrafish deficient in functional POPDC2 display sinus and AV node dysfunction. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=136 SRC="FIGDIR/small/24309755v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@803f01org.highwire.dtl.DTLVardef@1a89147org.highwire.dtl.DTLVardef@1d9d145org.highwire.dtl.DTLVardef@13a1645_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

1
Nature Communications
Springer Science and Business Media LLC · based on 483 published papers
Top 4%
5.6× avg
2
The American Journal of Human Genetics
Elsevier BV · based on 77 published papers
Top 0.8%
31× avg
3
Nature Genetics
Springer Science and Business Media LLC · based on 72 published papers
Top 1%
21× avg
4
Genetics in Medicine
Elsevier BV · based on 57 published papers
Top 2%
12× avg
5
PLOS Genetics
Public Library of Science (PLoS) · based on 39 published papers
Top 0.5%
29× avg
6
Human Genetics
Springer Science and Business Media LLC · based on 14 published papers
#1
93× avg
7
Nature
Springer Science and Business Media LLC · based on 58 published papers
Top 2%
9.9× avg
8
Human Genetics and Genomics Advances
Elsevier BV · based on 39 published papers
Top 0.3%
31× avg
9
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 54%
2.9%
10
npj Genomic Medicine
Springer Science and Business Media LLC · based on 18 published papers
Top 0.7%
29× avg
11
Circulation: Genomic and Precision Medicine
Ovid Technologies (Wolters Kluwer Health) · based on 30 published papers
Top 3%
10.0× avg
12
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences · based on 100 published papers
Top 5%
4.8× avg
13
Cell Genomics
Elsevier BV · based on 34 published papers
Top 2%
16× avg
14
eLife
eLife Sciences Publications, Ltd · based on 262 published papers
Top 17%
1.6× avg
15
Brain
Oxford University Press (OUP) · based on 69 published papers
Top 5%
4.1× avg
16
Genome Medicine
Springer Science and Business Media LLC · based on 56 published papers
Top 5%
5.1× avg
17
Science
American Association for the Advancement of Science (AAAS) · based on 46 published papers
Top 5%
5.0× avg
18
Human Molecular Genetics
Oxford University Press (OUP) · based on 28 published papers
Top 3%
10× avg
19
Cell
Elsevier BV · based on 28 published papers
Top 2%
13× avg
20
Human Genomics
Springer Science and Business Media LLC · based on 13 published papers
Top 2%
17× avg
21
Frontiers in Genetics
Frontiers Media SA · based on 32 published papers
Top 5%
4.5× avg
22
Genome Biology
Springer Science and Business Media LLC · based on 14 published papers
Top 1%
16× avg
23
BMC Medical Genomics
Springer Science and Business Media LLC · based on 12 published papers
Top 1%
13× avg
24
BMC Genomics
Springer Science and Business Media LLC · based on 15 published papers
Top 0.8%
17× avg
25
EMBO Molecular Medicine
Springer Science and Business Media LLC · based on 15 published papers
Top 3%
7.0× avg
26
European Journal of Human Genetics
Springer Science and Business Media LLC · based on 25 published papers
Top 3%
8.2× avg
27
Journal of Clinical Investigation
American Society for Clinical Investigation · based on 50 published papers
Top 5%
4.4× avg